Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 25% ± 6% | |
mast cell | 11 studies | 23% ± 10% | |
glutamatergic neuron | 10 studies | 48% ± 25% | |
microglial cell | 8 studies | 23% ± 6% | |
epithelial cell | 8 studies | 34% ± 16% | |
ciliated cell | 8 studies | 29% ± 9% | |
club cell | 7 studies | 30% ± 13% | |
natural killer cell | 6 studies | 18% ± 2% | |
respiratory goblet cell | 6 studies | 32% ± 12% | |
CD16-negative, CD56-bright natural killer cell, human | 6 studies | 19% ± 1% | |
basal cell | 6 studies | 31% ± 15% | |
type I pneumocyte | 6 studies | 28% ± 10% | |
type II pneumocyte | 6 studies | 32% ± 11% | |
GABAergic neuron | 6 studies | 45% ± 20% | |
macrophage | 6 studies | 32% ± 9% | |
dendritic cell | 5 studies | 22% ± 6% | |
endothelial cell of lymphatic vessel | 5 studies | 30% ± 7% | |
astrocyte | 5 studies | 24% ± 10% | |
squamous epithelial cell | 4 studies | 37% ± 22% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
neuron | 4 studies | 23% ± 8% | |
retinal bipolar neuron | 4 studies | 21% ± 3% | |
retinal rod cell | 4 studies | 20% ± 2% | |
cardiac muscle cell | 4 studies | 29% ± 3% | |
lymphocyte | 4 studies | 29% ± 8% | |
myeloid cell | 4 studies | 24% ± 5% | |
oligodendrocyte precursor cell | 4 studies | 21% ± 6% | |
monocyte | 4 studies | 31% ± 5% | |
fibroblast | 4 studies | 18% ± 3% | |
interneuron | 4 studies | 38% ± 13% | |
ionocyte | 3 studies | 30% ± 2% | |
secretory cell | 3 studies | 29% ± 12% | |
CD4-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
GABAergic interneuron | 3 studies | 19% ± 4% | |
retinal cone cell | 3 studies | 23% ± 4% | |
rod bipolar cell | 3 studies | 35% ± 8% | |
gamma-delta T cell | 3 studies | 24% ± 8% | |
retinal pigment epithelial cell | 3 studies | 31% ± 15% | |
T cell | 3 studies | 22% ± 1% | |
alveolar macrophage | 3 studies | 28% ± 8% | |
pericyte | 3 studies | 19% ± 4% | |
goblet cell | 3 studies | 41% ± 30% | |
adipocyte | 3 studies | 18% ± 2% | |
erythrocyte | 3 studies | 30% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1671.31 | 180 / 180 | 100% | 34.29 | 430 / 430 |
stomach | 100% | 1254.04 | 359 / 359 | 100% | 40.32 | 286 / 286 |
esophagus | 100% | 2310.20 | 1444 / 1445 | 100% | 37.74 | 183 / 183 |
intestine | 100% | 2092.74 | 966 / 966 | 100% | 50.76 | 526 / 527 |
lung | 100% | 1865.39 | 577 / 578 | 100% | 41.35 | 1154 / 1155 |
breast | 100% | 1790.35 | 459 / 459 | 99% | 32.77 | 1112 / 1118 |
bladder | 100% | 1593.57 | 21 / 21 | 99% | 35.95 | 501 / 504 |
prostate | 100% | 1599.26 | 245 / 245 | 99% | 34.26 | 499 / 502 |
thymus | 100% | 3432.36 | 653 / 653 | 99% | 52.62 | 601 / 605 |
uterus | 100% | 1394.02 | 170 / 170 | 99% | 38.42 | 454 / 459 |
kidney | 100% | 1445.65 | 89 / 89 | 98% | 26.43 | 885 / 901 |
brain | 97% | 1785.91 | 2562 / 2642 | 100% | 26.74 | 702 / 705 |
skin | 100% | 1809.69 | 1807 / 1809 | 94% | 20.32 | 446 / 472 |
pancreas | 95% | 772.67 | 313 / 328 | 98% | 37.16 | 175 / 178 |
adrenal gland | 100% | 1104.05 | 258 / 258 | 92% | 14.41 | 212 / 230 |
liver | 97% | 710.73 | 220 / 226 | 77% | 10.04 | 312 / 406 |
adipose | 100% | 1510.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.04 | 29 / 29 |
muscle | 100% | 3070.43 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1628.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.50 | 1 / 1 |
blood vessel | 100% | 1385.52 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 1126.97 | 807 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1300.86 | 847 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 73% | 9.01 | 58 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005515 | Molecular function | protein binding |
Gene name | FBXO34 |
Protein name | F-box only protein 34 F-box protein 34 |
Synonyms | FBX34 |
Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. . FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. . |
Accessions | G3V2U9 ENST00000679934.1 ENST00000680682.1 ENST00000681400.1 ENST00000681904.1 ENST00000313833.5 Q9NWN3 ENST00000440021.1 ENST00000555280.1 ENST00000681074.1 ENST00000680658.1 |